Volume 31, Issue 3, March 2013

ISSN: 1170-7690 (Print) 1179-2027 (Online)

In this issue (9 articles)

  1. Editorial

    Improving Confidence in Observational Studies

    Eberechukwu Onukwugha Pages 177-179
    Download PDF (139KB) View Article

  2. Commentary

    What Evidence Is There for the Reimbursement of Personalised Medicine?

    Peter S. Hall, Christopher McCabe Pages 181-183
    Download PDF (160KB) View Article

  3. No Access

    Review Article

    Trastuzumab for the Treatment of HER2-Positive Metastatic Gastric Cancer

    Eldon Spackman, Stephen Rice, Gill Norman, Dong-Churl Suh… Pages 185-194
    Look Inside Get Access

  4. No Access

    Review Article

    Cost Effectiveness of Antiarrhythmic Medications in Patients Suffering from Atrial Fibrillation

    Bernd Brüggenjürgen, Stefan Kohler, Nadja Ezzat, Thomas Reinhold… Pages 195-213
    Look Inside Get Access

  5. No Access

    Systematic Review

    Influence of Pharmacogenomic Profiling Prior to Pharmaceutical Treatment in Metastatic Colorectal Cancer on Cost Effectiveness

    Martin Frank, Thomas Mittendorf Pages 215-228
    Look Inside Get Access

  6. No Access

    Original Research Article

    The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada

    Jean H. E. Yong, Jaclyn Beca, Jeffrey S. Hoch Pages 229-236
    Look Inside Get Access

  7. No Access

    Original Research Article

    The Economic Burden of Depression in Switzerland

    Yuki Tomonaga, Josef Haettenschwiler, Martin Hatzinger… Pages 237-250
    Look Inside Get Access

  8. No Access

    Correspondence

    The State of Health Economic Research in South Africa

    Jeff Gow, Michael Strauss, Alan Whiteside Pages 251-253
    Look Inside Get Access

  9. No Access

    Correspondence

    The Authors’ Reply to Gow et al.: “The State of Health Economic Research in South Africa”

    Paul Gavaza, Karen L. Rascati, Abiola O. Oladapo, Star Khoza Pages 255-256
    Get Access